GuidelineTrials2014
Effectiveness guidance document (EGD) for Chinese medicine trials: a consensus document.
Guideline in Trials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Assessing group medical visits for the management of chronic pain in older adults: a systematic review and meta-analysis.The Gerontologist · 2026Pooled it
- Reporting of Protocol Rationale and Content Validity in Randomized Clinical Trials of T'ai Chi: A Systematic Evaluation.Journal of alternative and complementary medicine (New York, N.Y.) · 2019Pooled it
- The Mind Body-Wellness in Supportive Housing (Mi-WiSH) study: Design and rationale of a cluster randomized controlled trial of Tai Chi in senior housing.Contemporary clinical trials · 2017Trial
- International standards and good practice guidelines in traditional, complementary and integrative medicine: a scoping review.Frontiers in pharmacology · 2026Article
- Protocol for a scoping review of traditional medicine research methods, methodologies, frameworks and strategies.Frontiers in medicine · 2024Article
- Bangpungtongsung-san for patients with major depressive disorder: study protocol for a randomized controlled phase II clinical trial.BMC complementary medicine and therapies · 2023Article
- How to design high quality acupuncture trials-a consensus informed by evidence.BMJ (Clinical research ed.) · 2022Article
- Patients' perceptions on non-specific effects of acupuncture: Qualitative comparison between responders and non-responders.Integrative medicine research · 2022Article
- Regulation and status of herbal medicine clinical trials in Korea: a narrative review.Integrative medicine research · 2021Review
- Article
- The Integrative Migraine Pain Alleviation through Chiropractic Therapy (IMPACT) trial: Study rationale, design and intervention validation.Contemporary clinical trials communications · 2020Article
- Interdisciplinary Relationship Models for Complementary and Integrative Health: Perspectives of Chinese Medicine Practitioners in the United States.Journal of alternative and complementary medicine (New York, N.Y.) · 2019Article
- Neuroimaging and Neuromonitoring Effects of Electro and Manual Acupuncture on the Central Nervous System: A Literature Review and Analysis.Evidence-based complementary and alternative medicine : eCAM · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
backgroundThere is a need for more Comparative Effectiveness Research (CER) on Chinese medicine (CM) to inform clinical and policy decision-making. This document aims to provide consensus advice for the design of CER trials on CM for researchers. It broadly aims to ensure more adequate design and optimal use of resources in generating evidence for CM to inform stakeholder decision-making.
methodsThe Effectiveness Guidance Document (EGD) development was based on multiple consensus procedures (survey, written Delphi rounds, interactive consensus workshop, international expert review). To balance aspects of internal and external validity, multiple stakeholders, including patients, clinicians, researchers and payers were involved in creating this document.
resultsRecommendations were developed for "using available data" and "future clinical studies". The recommendations for future trials focus on randomized trials and cover the following areas: designing CER studies, treatments, expertise and setting, outcomes, study design and statistical analyses, economic evaluation, and publication.
conclusionThe present EGD provides the first systematic methodological guidance for future CER trials on CM and can be applied to single or multi-component treatments. While CONSORT statements provide guidelines for reporting studies, EGDs provide recommendations for the design of future studies and can contribute to a more strategic use of limited research resources, as well as greater consistency in trial design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.